Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


China's Xi hails trade progress in Trump summit, sends Taiwan warning
Senior UK minister resigns, piling pressure on PM Starmer to quit
Ukraine's anti-corruption court places Zelenskyy's former chief of staff under arrest
Philippine Senate to convene as court next week for VP Duterte impeachment
Nearly 90 killed as storm lashes India's Uttar Pradesh
Russia pounds Ukraine in massive air attack
GCC interior ministers hold emergency meeting in Riyadh
Gunshots fired in standoff at Philippine Senate over ICC suspect
